Clinical Trials Browser

Phase 1 × Interventional × bemcentinib × Clear all

Mesothelioma, Malignant, COVID-19, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Melanoma, Myelodysplastic Syndromes, Pancreatic Neoplasms, Leukemia, Myeloid, Acute

NCT02922777 2024-02-21

Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.

Phase 1 Completed

23 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

8479217

Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.